AIM ImmunoTech Inc. (AIMI) stock news · rev $170.0K
AIM ImmunoTech Inc. (AIMI) is a biotechnology company listed on US.
This AIMI news page leads with what AIM ImmunoTech Inc. filed — not a scraped headline mill.
No cached 8-K sentence for AIMI yet. We will not pad this page with generic market recap.
Latest reported AIMI revenue for 2024-12-31 was $170.0K. Net income was -$17.3M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. AIMI currently screens at market cap $878.9K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AIMI stock page; for the tape open the quote page.
Not investment advice.